ArticleJournal of the National Cancer Institute2023

Expression of Concern to: Randomized Trial of First-Line Tyrosine Kinase Inhibitor With or Without Radiotherapy for Synchronous Oligometastatic EGFR-Mutated Non-Small Cell Lung Cancer.

No numbers read from the abstract.

Not cited yet